 foscarnet therapi patient aid acyclovir-resist varicella-zost viru infect object foscarnet potenti efficaci treatment acyclovir-resist mucocutan varicella-zost infect patient acquir immunodefici syndrom aid design open-label studi set univers medic center patient patient aid thymidine-kinase-defici -alter strain varicella-zost viru intervent foscarnet mg/kg bodi hour infus day main result patient respons therapi test patient cultur neg viru foscarnet therapi result fluoresc antigen posit therapi patient patient concomit clinic failur patient patient complet emerg resist serial specimen foscarnet therapi conclus foscarnet effect toler antivir agent patient acyclovir-resist varicella-zost viru infect optim dosag durat therapi requir studi relat clinic find in-vitro suscept result